At a Glance
Stratify 360 helped a university-based diabetes care center leverage generative AI for prediabetes diagnosis and subsequent preventive care interventions to narrow the gap between those who are predisposed to diabetes and those who follow a preventive care program.
Diabetes is a chronic disease affecting more than 350 million people worldwide, and its prevalence is expected to increase in the coming years. In addition, among US adults, research revealed that 38.0% had pre-diabetes, while only 19.0% of adults with pre-diabetes were diagnosed as such.
The Story
Stratify 360 helped the care center leverage generative AI to assist patients with diabetes management. Blood glucose monitoring technology is being used to provide data to generative AI for analysis and patient-specific information. Continuous glucose monitoring (CGM) devices provide instant, real-time measurements of blood glucose levels and rates of change, alerting the patient to impending glycemic events and motivating the patient to take remedial action.
Generative AI-powered chatbots provide patients with quick advice on how to manage their chronic conditions. Chatbots answer patient questions, provide advice on how to live a healthy lifestyle and suggest individualized meal plans for the patient.
